Literature DB >> 30170011

Digital Air Leak Monitoring for Lung Resection Patients: A Randomized Controlled Clinical Trial.

Madelaine Plourde1, Ahmed Jad2, Patrick Dorn3, Kyla Harris3, Aneil Mujoomdar3, Harry Henteleff3, Daniel French3, Drew Bethune3.   

Abstract

BACKGROUND: Digital chest drainage devices objectively measure airflow to guide chest tube management. There are contradictory results regarding their utility in reducing length of stay and chest tube duration. The objective of this study was to compare digital and analog devices in patients undergoing anatomic lung resection.
METHODS: A single-institution randomized trial was conducted. Patients undergoing anatomic lung resection between November 2013 and July 2016 were randomized to digital or analog devices. Chest tubes were managed using a standardized protocol. Hospital length of stay and chest tube duration were primary outcomes. Chest tube clamping, number of chest roentgenograms, and chest tube reinsertion were secondary outcomes.
RESULTS: The study randomized 215 patients, with 107 in the digital group and 108 in the analog group. There was no significant difference in outcomes for length of stay (p = 1), chest tube duration (p = 0.71), number of chest roentgenograms performed (p = 0.78) or need for chest tube reinsertion (p = 0.21). The only significant finding was a higher number of patients who had their chest tubes clamped before removal, with 47% in the analog group and 19% in the digital group (p < 0.0001).
CONCLUSIONS: Digital devices did not result in reduced chest tube duration or hospital length of stay. Approximately one half of the patients in the analog group had their chest tubes clamped before removal because of uncertainty in air leak assessment. Digital devices provided objective quantification of air leaks that decreased chest tube clamping.
Copyright © 2018 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30170011     DOI: 10.1016/j.athoracsur.2018.06.080

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

Review 1.  Optimal management of postoperative parenchymal air leaks.

Authors:  Daniel G French; Madelaine Plourde; Harry Henteleff; Aneil Mujoomdar; Drew Bethune
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

2.  Complications after Chest Tube Removal and Reinterventions in Patients with Digital Drainage Systems.

Authors:  Yi-Ying Lee; Po-Kuei Hsu; Chien-Sheng Huang; Yu-Chung Wu; Han-Shui Hsu
Journal:  J Clin Med       Date:  2019-12-01       Impact factor: 4.241

3.  Enhanced Recovery Pathway in Lung Resection Surgery: Program Establishment and Results of a Cohort Study Encompassing 1243 Consecutive Patients.

Authors:  Yen-Lan Nguyen; Elena Maiolino; Vincent De Pauw; Mathilde Prieto; Antonio Mazzella; Jean-Baptiste Peretout; Agnès Dechartres; Christophe Baillard; Antonio Bobbio; Elisa Daffré; Marco Alifano
Journal:  Cancers (Basel)       Date:  2022-03-29       Impact factor: 6.639

4.  Promising Effects of Digital Chest Tube Drainage System for Pulmonary Resection: A Systematic Review and Network Meta-Analysis.

Authors:  Po-Chih Chang; Kai-Hua Chen; Hong-Jie Jhou; Cho-Hao Lee; Shah-Hwa Chou; Po-Huang Chen; Ting-Wei Chang
Journal:  J Pers Med       Date:  2022-03-22

5.  Use of a novel digital drainage system after pulmonary resection.

Authors:  Travis C Geraci; Audrey Sorensen; Les James; Stacey Chen; Mohamed El Zaeedi; Robert J Cerfolio; Michael Zervos
Journal:  J Thorac Dis       Date:  2022-09       Impact factor: 3.005

6.  Multicenter randomized controlled trial comparing digital and traditional chest drain in a VATS pulmonary lobectomy cohort: interim analysis.

Authors:  Paolo Mendogni; Davide Tosi; Giuseppe Marulli; Giovanni Maria Comacchio; Sara Pieropan; Veronica Rossi; Debora Brascia; Luigi Gaetano Andriolo; Giovanna Imbriglio; Gianluca Bonitta; Camillo Lopez; Federico Rea; Mario Nosotti
Journal:  J Cardiothorac Surg       Date:  2021-07-05       Impact factor: 1.637

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.